Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
107.61B | 110.58B | 104.38B | 108.28B | 92.64B | 76.90B | Gross Profit |
33.73B | 33.94B | 31.16B | 33.73B | 29.14B | 23.98B | EBIT |
12.99B | 13.27B | 11.05B | 12.75B | 9.73B | 7.22B | EBITDA |
16.32B | 19.03B | 15.71B | 16.89B | 13.52B | 10.73B | Net Income Common Stockholders |
9.16B | 9.43B | 8.67B | 8.53B | 6.31B | 4.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
41.11B | 44.90B | 42.45B | 46.90B | 48.75B | 47.62B | Total Assets |
146.64B | 152.99B | 140.78B | 135.36B | 122.58B | 108.21B | Total Debt |
0.00 | 0.00 | 0.00 | 490.00M | 0.00 | 0.00 | Net Debt |
-41.11B | -44.90B | -42.45B | -46.41B | -48.75B | -47.62B | Total Liabilities |
29.05B | 29.83B | 27.81B | 30.24B | 28.24B | 21.54B | Stockholders Equity |
117.59B | 123.15B | 112.97B | 105.13B | 94.33B | 86.68B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.33B | -2.96B | -1.81B | 5.19B | 7.86B | Operating Cash Flow |
0.00 | 16.01B | 11.97B | 9.12B | 9.76B | 10.64B | Investing Cash Flow |
0.00 | -10.98B | -12.31B | -11.20B | -9.66B | -3.74B | Financing Cash Flow |
0.00 | -4.90B | -4.15B | -2.50B | -2.36B | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $1.02T | 12.54 | 10.10% | 2.72% | 3.28% | 6.55% | |
74 Outperform | $608.62B | 18.77 | 3.69% | 4.69% | 3.40% | -35.14% | |
73 Outperform | ¥138.10B | 14.58 | 3.16% | 5.94% | 9.00% | ||
72 Outperform | $279.17B | 11.12 | 7.16% | 4.72% | 10.04% | -13.43% | |
72 Outperform | $1.06T | 23.62 | 2.49% | 4.28% | 0.46% | -62.37% | |
51 Neutral | $2.03B | -1.27 | -21.09% | 4.14% | 2.90% | -30.49% | |
51 Neutral | $217.82B | 11.14 | -1.23% | 4.93% | 3.96% | -116.60% |